Pre-treatment immune-related markers predict disease outcomes in non-small cell lung cancer patients treated with chemoradiation and durvalumab Meeting Abstract


Authors: Thor, M.; Shepherd, A. F.; Apte, A.; Offin, M.; Wu, A. J.; Gelblum, D.; Simone, C. B. 2nd; Rimner, A.; Gomez, D. R.; Deasy, J. O.; Shaverdian, N.
Abstract Title: Pre-treatment immune-related markers predict disease outcomes in non-small cell lung cancer patients treated with chemoradiation and durvalumab
Meeting Title: 63rd Annual Meeting of the American Society for Radiation Oncology (ASTRO 2021)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 111
Issue: 3 Suppl.
Meeting Dates: 2021 Oct 24-27
Meeting Location: Chicago, IL
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2021-11-01
Start Page: S11
Language: English
ACCESSION: WOS:000715803801360
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2021.07.057
Notes: Meeting Abstract: 19 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daphna Y Gelblum
    228 Gelblum
  2. Daniel R Gomez
    239 Gomez
  3. Andreas Rimner
    527 Rimner
  4. Abraham Jing-Ching Wu
    404 Wu
  5. Joseph Owen Deasy
    525 Deasy
  6. Aditya Apte
    204 Apte
  7. Maria Elisabeth Thor
    149 Thor
  8. Michael David Offin
    171 Offin
  9. Annemarie Fernandes Shepherd
    103 Shepherd